<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01946932</url>
  </required_header>
  <id_info>
    <org_study_id>TTMcogsub</org_study_id>
    <nct_id>NCT01946932</nct_id>
  </id_info>
  <brief_title>Cognitive Impairment Following Cardiac Arrest and Target Temperature Management</brief_title>
  <official_title>Cognitive Impairment Following Cardiac Arrest and Target Temperature Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Copenhagen University Hospital, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Santa Maria Degli Angeli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Copenhagen Trial Unit, Center for Clinical Intervention Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of Wales</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a steering group approved substudy to the Target Temperature Management trial (TTM,
      ClinicalTrials.gov Identifier: NCT01020916). TTM compares the effect of two strictly
      controlled temperature regimes for survivors of out-of-hospital cardiac arrest.

      The primary aim of this sub-study is to compare the amount of cognitive impairment in cardiac
      arrest survivors treated with 33 degrees and 36 degrees and with a matched group of control
      patients with myocardial infarction.

      Our secondary aims are:

        -  To investigate the impact of cognitive impairment on our patients' ability to
           participate in society and their health related quality of life.

        -  To investigate the relationship between our patients cognitive impairments and their
           relatives/informants health related quality of life and feelings of burden.

        -  To test the hypothesis that the simple cognitive screening battery used in the TTM main
           trial is sensitive enough to detect all patients with significant cognitive disability.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rivermead Behavioural Memory Test (RBMT)</measure>
    <time_frame>180 days after Cardiac Arrest (CA) or Myocardial Infarction (MI)</time_frame>
    <description>Memory test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frontal Assessment Battery (FAB)</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>Screening of Executive functions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symbol Digit Modalities Test (SDMT)</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>Assess attention, mental speed and concentration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mayo-Portland Adaptability Inventory-4 (MPAI-4)</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>Self rating of impairments, adjustment, and participation (in the society)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-Form Questionnaire 36 version 2 (SF-36v2)</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>Questionnaire of health-related quality of life, both for patient and informant/relative/caregiver</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zarit Burden Interview</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>Questionnaire for caregiver/informant/relative's perception of burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression rating Scale (HADS)</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>Anxiety and Depression questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Two Simple Questions (TSQ)</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>Self rating of everyday activities and cognition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Informant Questionnaire on Cognitive Decline (IQCODE)</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>Patients cognitive functioning in everyday life, questionnaire completed by informant/relative/caregiver</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MiniMental Status Examination (MMSE)</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>General cognitive screening</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral Performance Category (CPC)</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>Scale for general neurological outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified Rankin Scale</measure>
    <time_frame>180 days after CA or MI</time_frame>
    <description>Scale for general outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">287</enrollment>
  <condition>Heart Arrest</condition>
  <condition>Out-of-hospital Cardiac Arrest</condition>
  <condition>Cognition Disorders</condition>
  <condition>Brain Injury</condition>
  <arm_group>
    <arm_group_label>Cardiac Arrest 33°</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>survivors with temperature treatment 33°</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cardiac Arrest survivors 36°</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>survivors with temperature treatment 36°</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Temperature treatment</intervention_name>
    <arm_group_label>Cardiac Arrest 33°</arm_group_label>
    <arm_group_label>Cardiac Arrest survivors 36°</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Out-of-Hospital Cardiac Arrest (OHCA)of presumed cardiac cause

          -  Unconsciousness after sustained return of spontaneous circulation (ROSC)

        Exclusion Criteria at time for inclusion in the TTM study:

          -  Known bleeding diathesis

          -  Suspected or confirmed acute intracranial bleeding

          -  Suspected or confirmed stroke

          -  Unwitnessed asystole

          -  Known limitations in therapy and Do Not Resuscitate-order

          -  Known disease making 180 days survival unlikely

          -  Known prearrest status Cerebral Performance Category (CPC)3 or 4

          -  Temperature &lt;30°on admission

               -  4 hours (240 minutes) from ROSC to screening

          -  Systolic blood pressure &lt;80 mm Hg in spite of fluid loading/vasopressor and/or
             inotropic medication/intra aortic balloon pump

          -  In-hospital cardiac arrest

          -  OHCA of presumed non-cardiac arrest cause

        Additional Exclusion criteria for the sub-study:

          -  Disability to speak the site language well enough to complete tests without
             interpreter

          -  Controls should never have suffered a cardiac arrest
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tobias Cronberg, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Clinical Sciences, Lund University, Lund, Sweden and Department of Neurology, Skåne University Hospital, Lund, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Niklas Nielsen, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Sciences, Lund University, Lund Sweden and Department of Anesthesia and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jesper Kjaergaard, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Heart Centrem Copenhagen University, Copenhagen, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janneke Horn, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Intensive Care, Academic Medical Centrum, Amsterdam, Netherlands</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tommaso Pellis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intensive Care Unit Santa Maria Degli Angeli, Pordenonde, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthew P Wise, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Adult Critical Care, University Hospital of Wales, Cardiff, Untied Kingdom</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gisela Lilja, OT</last_name>
    <role>Study Director</role>
    <affiliation>Lund University Hospital, Lund, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Martino Hospital</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Maria degli Angeli Hospital</name>
      <address>
        <city>Pordenone</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Universitario di Cattinaria</name>
      <address>
        <city>Trieste</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum (AMC)</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouwe Gasthuis</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rijnstate Hospital</name>
      <address>
        <city>Arnhem</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeuwarden Hospital</name>
      <address>
        <city>Leeuwarden</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital, Thorax</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital, Östra</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsingborg Hospital</name>
      <address>
        <city>Helsingborg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karlstad Central Hospital</name>
      <address>
        <city>Karlstad</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skåne University Hospital, Lund</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skåne University Hospital, Malmö</name>
      <address>
        <city>Malmoe</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Wales</name>
      <address>
        <city>Cardiff</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Georges' Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Berkshire NHS Foundation Trust</name>
      <address>
        <city>Reading</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.ttm-trial.org</url>
  </link>
  <reference>
    <citation>Cronberg T, Lilja G, Rundgren M, Friberg H, Widner H. Long-term neurological outcome after cardiac arrest and therapeutic hypothermia. Resuscitation. 2009 Oct;80(10):1119-23. doi: 10.1016/j.resuscitation.2009.06.021. Epub 2009 Jul 23.</citation>
    <PMID>19631442</PMID>
  </reference>
  <reference>
    <citation>Nielsen N, Wetterslev J, al-Subaie N, Andersson B, Bro-Jeppesen J, Bishop G, Brunetti I, Cranshaw J, Cronberg T, Edqvist K, Erlinge D, Gasche Y, Glover G, Hassager C, Horn J, Hovdenes J, Johnsson J, Kjaergaard J, Kuiper M, Langørgen J, Macken L, Martinell L, Martner P, Pellis T, Pelosi P, Petersen P, Persson S, Rundgren M, Saxena M, Svensson R, Stammet P, Thorén A, Undén J, Walden A, Wallskog J, Wanscher M, Wise MP, Wyon N, Aneman A, Friberg H. Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design. Am Heart J. 2012 Apr;163(4):541-8. doi: 10.1016/j.ahj.2012.01.013.</citation>
    <PMID>22520518</PMID>
  </reference>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2013</study_first_submitted>
  <study_first_submitted_qc>September 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2013</study_first_posted>
  <last_update_submitted>December 4, 2013</last_update_submitted>
  <last_update_submitted_qc>December 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Induced hypothermia</keyword>
  <keyword>Mild induced hypothermia</keyword>
  <keyword>Resuscitation</keyword>
  <keyword>Therapeutic hypothermia</keyword>
  <keyword>Neurological function</keyword>
  <keyword>Cardiovascular diseases</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Cognition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

